Updated:
Mint Venture Partners
Founded in 2020, Mint Venture Partners is an accelerator/incubator and venture studio based in Seoul, South Korea. The firm prefers to create new startups, and...
Mint Venture Partners
Founded in 2020, Mint Venture Partners is an accelerator/incubator and venture studio based in Seoul, South Korea. The firm prefers to create new startups, and is focused on the biotechnology, diagnostics & devices, digital health, and medical care areas.
General information
Firm type
Venture Capital
Year founded
2020
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Principals
Jae-Hoon Song
Founder & CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Mint Venture Partners?
Founder and CEO Jae-Hoon Song, MD, PhD, leads the firm. His background as an infectious disease physician, former president of Samsung Medical Center, and former chairman of CHA Bio Group makes him the central decision-maker. The firm does not list additional investment partners or a formal investment committee structure on its current website.
Is Mint Venture Partners structured as a single family office or a traditional venture firm?
The firm operates as a private equity and venture platform, not a family office. It describes itself as a ‘global venture platform’ rather than a fund, though it does not disclose its legal structure, fund series, or limited partner base publicly. The emphasis on startup founding and incubation suggests it may use a hybrid or holding-company approach.
Which sectors does Mint Venture Partners target?
The firm focuses on bio-healthcare. Based on its stated mission and the founder’s career at Samsung Medical Center and CHA Bio Group, activity likely spans digital health, medical devices, biopharma, and healthcare services. No explicit sector exclusions are listed.
What investment stages does Mint Venture Partners typically target?
Altss research tags the firm as active in seed, start-up, and early-stage rounds. The website narrative around founding and incubating companies reinforces an entry point at formation or pre-clinical validation rather than later-stage growth equity.
Does Mint Venture Partners maintain philanthropic structures, and how are they separated?
Jae-Hoon Song founded and chairs the Asia Pacific Foundation for Infectious Diseases (APFID), a separate non-profit entity. The firm’s limited public materials do not indicate whether APFID co-invests, shares deal flow, or operates independently from Mint Venture Partners’ for-profit activities.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: